Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis

• Cecilia Bosco,

  Affiliation King’s College London, School of Medicine, Division of Cancer Studies, Cancer Epidemiology Group, London, United Kingdom

  ⨯
• Danielle Crawley,

  Affiliations King’s College London, School of Medicine, Division of Cancer Studies, Cancer Epidemiology Group, London, United Kingdom, Department of Oncology, Guy’s & St Thomas’ NHS Foundation Trust, London, United Kingdom

  ⨯
• Jan Adolfsson,

  Affiliation Karolinska Institute, CLINTEC Department, Stockholm, Sweden

  ⨯
• Sarah Rudman,

  Affiliation Department of Oncology, Guy’s & St Thomas’ NHS Foundation Trust, London, United Kingdom

  ⨯
• Mieke Van Hemelrijck

  * E-mail: mieke.vanhemelrijck@kcl.ac.uk

  Affiliation King’s College London, School of Medicine, Division of Cancer Studies, Cancer Epidemiology Group, London, United Kingdom

  ⨯